Standard BioTools Inc. (LAB)
NASDAQ: LAB
· Real-Time Price · USD
1.26
0.03 (2.44%)
At close: Aug 18, 2025, 3:59 PM
1.29
1.95%
After-hours: Aug 18, 2025, 07:56 PM EDT
Standard BioTools Revenue
Standard BioTools reported an annual revenue of $174.43M, reflecting a 64.03% growth. For the quarter ending June 30, 2025, Standard BioTools generated $21.76M in revenue.
Revenue (ttm)
174.43M
Revenue Growth
64.03%
Price / Sales Ratio
3.54
Revenue / Employee
214.29K
Employees
814
Market Cap
480.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 174.43M | +64.03% |
Dec 31, 2023 | 106.34M | +8.57% |
Dec 31, 2022 | 97.95M | -24.99% |
Dec 31, 2021 | 130.58M | -5.47% |
Dec 31, 2020 | 138.14M | +17.83% |
Dec 31, 2019 | 117.24M | +3.79% |
Dec 31, 2018 | 112.96M | +10.82% |
Dec 31, 2017 | 101.94M | -2.40% |
Dec 31, 2016 | 104.45M | -8.95% |
Dec 31, 2015 | 114.71M | -1.50% |
Dec 31, 2014 | 116.46M | +63.60% |
Dec 31, 2013 | 71.18M | +36.02% |
Dec 31, 2012 | 52.33M | +22.09% |
Dec 31, 2011 | 42.87M | +27.73% |
Dec 31, 2010 | 33.56M | +32.06% |
Dec 31, 2009 | 25.41M | +65.58% |
Dec 31, 2008 | 15.35M | +110.96% |
Dec 31, 2007 | 7.28M | +13.71% |
Dec 31, 2006 | 6.4M | -95.10% |
Dec 31, 2001 | 130.58M | n/a |